# OnCo record lymphoma-ev-ctdna-instead-of-the-interim-scan (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/lymphoma-ev-ctdna-instead-of-the-interim-scan/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "lymphoma-ev-ctdna-instead-of-the-interim-scan" ;
  schema:name "Use circulating tumour DNA instead of the interim scan to decide what happens next"@en ;
  schema:alternateName "Molecular response-adapted lymphoma therapy"@en, "ctDNA-guided de-escalation in lymphoma"@en ;
  schema:description "A blood test detects lymphoma left behind better than a scan does, and no trial has yet used it to change anyone's treatment."@en ;
  schema:url <https://onco.cc/ideas/lymphoma-ev-ctdna-instead-of-the-interim-scan/> ;
  schema:dateModified "2026-10-01"^^xsd:date ;
  onco:tag "lymphoma-evidence" ;
  onco:related <https://onco.cc/roadmaps/lymphoma-roadmap/>, <https://onco.cc/roadmaps/ctdna-tests/> ;
  onco:cancers <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/early-stage-classical-hodgkin-lymphoma/>, <https://onco.cc/cancers/follicular-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/>, <https://onco.cc/fronts/early-detection/> ;
  onco:technologies <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/terms/ngs/>, <https://onco.cc/technologies/pet-ct/> ;
  onco:terms <https://onco.cc/terms/ctdna/>, <https://onco.cc/terms/mrd/>, <https://onco.cc/terms/deauville-score/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-dormancy-mrd/>, <https://onco.cc/bottlenecks/b-biomarker-validation/>, <https://onco.cc/bottlenecks/b-trial-design/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-scherer-ctdna-lymphoma-subtypes-genome-evolution-sci-transl-med-2016/>, <https://onco.cc/key-papers/paper-kurtz-j-clin-oncol/>, <https://onco.cc/key-papers/paper-kurtz-nat-biotechnol/>, <https://onco.cc/key-papers/paper-ghsg-hd16-pet-guided-early-favourable-hodgkin-jco-2019/> .
